NCT07437456Active, not recruiting
AF-CARD Registry (Real-World Clinical Practice Registry of Patients With Atrial Fibrillation)
Source: ClinicalTrials.gov · Last updated 11 Sept 2026
Brief summary (registry, in English)
Multicenter Non-Interventional Real-World Clinical Practice Registry of Patients with Atrial Fibrillation. The primary objective of the registry is an epidemiological assessment of the characteristics, clinical outcomes, and therapeutic approaches in patients with atrial fibrillation and a CHA₂DS₂-VASc score of no more than 2 for men and no more than 3 for women.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 3500 (estimated)
- First submitted
- 22 Feb 2026
- Start date
- Jul 2026
- Primary completion date
- Sept 2028
- Lead sponsor
- Eurasian Association of Therapists
- Diseases
- Atrial fibrillation
- NCT number
- NCT07437456
What you commit to
- Study type: Observational
- Planned participants: 3500
- From Jul 2026 to the primary completion date, Sept 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient withdrawal of consent for further participation in the study;
- Identification of factors precluding further patient participation in the study (at the physician's discretion).
Who the study is looking for
- Male or female patients aged 18 to 64 years at the time of data registration;
- Presence of a specialist-confirmed diagnosis of atrial fibrillation;
- CHA₂DS₂-VASc score ranging from 0 to 2 for men and from 1 to 3 for women.
- Non-inclusion criteria for the retrospective part:
- Age under 18 years;
- Age over 64 years;
- CHA₂DS₂-VASc score greater than 2 for men and greater than 3 for women;
- Inability to undergo screening examination and follow-up;
- Organ or tissue transplantation less than 5 years prior to study enrollment;
- Open heart surgery (coronary artery bypass grafting, valve replacement, reconstructive aortic surgery) within 6 months prior to study enrollment;
- Established diagnosis of dementia of any severity and/or established diagnosis of moderate or severe encephalopathy, as well as other conditions precluding independent regular medication intake.
- Prospective Part
- Male or female patients aged 18 to 64 years at the time of data registration;
- Presence of a specialist-confirmed diagnosis of atrial fibrillation;
- CHA₂DS₂-VASc score ranging from 0 to 2 for men and from 1 to 3 for women at the time of screening.
- Non-inclusion criteria for the prospective part:
- Age under 18 years;
- Age over 64 years;
- CHA₂DS₂-VASc score greater than 2 for men and greater than 3 for women;
- Inability to undergo screening examination and follow-up;
- Organ or tissue transplantation less than 5 years prior to study enrollment;
- Open heart surgery (coronary artery bypass grafting, valve replacement, reconstructive aortic surgery) within 6 months prior to study enrollment;
- Established diagnosis of dementia of any severity and/or established diagnosis of moderate or severe encephalopathy, as well as other conditions precluding independent regular medication intake.
Criteria the registry did not label
- Retrospective Part The retrospective part will include patients who attended a physician consultation for atrial fibrillation three years ago and who met the inclusion criteria at that time.
Age in the registry: 18 years to 64 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Eurasian Association of Therapists Coordinator of this site? Confirm its status | Moscow | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.